Overview

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Status:
Completed

Trial end date:
2006-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of the combination of mebendazole plus quinfamide for the treatment of intestinal helminthiasis and amoebiasis in Mexican population.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen-Cilag Ltd.

Treatments:

DMP 777
Mebendazole
Piperazine
Piperazine citrate